Safety of human albumin as a constituent of biologic therapeutic products.
McClelland
D B
DB
Edinburgh and South East Scotland Blood Transfusion Service, Royal Infirmary, UK.
D001779:Blood Coagulation Factors / Q000009:adverse effects* / Q000627:therapeutic use; D004340:Drug Contamination; D006801:Humans; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use; D012709:Serum Albumin / Q000009:adverse effects* / Q000627:therapeutic use; D065227:Transfusion Reaction; D014777:Virus Diseases / Q000517:prevention & control* / Q000635:transmission*; D014780:Viruses / Q000302:isolation & purification*
D001779:Blood Coagulation Factors; D011994:Recombinant Proteins; D012709:Serum Albumin